Mariateresa Lena
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR.
Journal: Frontiers in pharmacology
Published: July 07, 2025
In silico, in vitro and ex vivo characterization of cystic fibrosis transmembrane conductance regulator pathogenic variants localized in the fourth intracellular loop and their rescue by modulators.
Journal: British journal of pharmacology
Published: March 14, 2025
Distinct Responses of Cystic Fibrosis Epithelial Cells to SARS-CoV-2 and Influenza A Virus.
Journal: American journal of respiratory cell and molecular biology
Published: September 23, 2024
Pharmacological rescue of the G85E CFTR variant by preclinical and approved modulators.
Journal: Frontiers in pharmacology
Published: September 10, 2024
De novo variants in DENND5B cause a neurodevelopmental disorder.
Journal: American journal of human genetics
Published: August 31, 2023
Clinical Consequences and Functional Impact of the Rare S737F CFTR Variant and Its Responsiveness to CFTR Modulators.
Journal: International journal of molecular sciences
Published: February 27, 2023
Rescue by elexacaftor-tezacaftor-ivacaftor of the G1244E cystic fibrosis mutation's stability and gating defects are dependent on cell background.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: September 08, 2022
The L467F-F508del Complex Allele Hampers Pharmacological Rescue of Mutant CFTR by Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients: The Value of the Ex Vivo Nasal Epithelial Model to Address Non-Responders to CFTR-Modulating Drugs.
Journal: International journal of molecular sciences
Published: February 20, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026